# Baxter International Inc.

> Baxter International is a Deerfield, Illinois-based medtech company whose products sit in the everyday machinery of care: IV solutions and pumps, hospital beds, patient monitors, diagnostic tools, surgical products, respiratory devices, nutrition therapies and injectable medicines. After selling its kidney-care operation in 2025, Baxter is a more focused hospital, clinic and home-care supplier, combining consumables, devices, software, pharmaceuticals and support for health systems in more than 100 countries.

- **Founded:** 1931
- **Headquarters:** Deerfield, United States
- **Founders:** Dr. Donald Baxter (Co-founder), Dr. Ralph Falk (Co-founder)
- **Team size:** Approximately 37,500 employees as of June 2026
- **Products:** Infusion therapies and platforms, Novum IQ Infusion Platform, Advanced Surgery, Care and Connectivity Solutions, Front Line Care
- **Notable:** Became the first commercial manufacturer of prepared IV solutions after its founding in 1931., Built a portfolio sold in more than 100 countries and used by more than 350 million patients annually., Completed the $12.5 billion acquisition of Hillrom in 2021, adding smart beds, patient monitoring, diagnostics and surgical technologies.

## Products & services

- **Infusion therapies and platforms** — Sterile IV solutions, administration sets, smart infusion pumps, parenteral nutrition, drug compounding and connectivity software.
- **Novum IQ Infusion Platform** — Large-volume and syringe infusion pumps with Dose IQ safety software and enterprise connectivity for electronic medical record interoperability.
- **Advanced Surgery** — Hemostats, sealants, adhesion barriers and other products used to control bleeding and support surgical workflows.
- **Care and Connectivity Solutions** — Smart hospital beds, patient support systems, care communications, operating-room integration and workflow technologies.
- **Front Line Care** — Welch Allyn diagnostic devices, patient monitoring, vision screening and respiratory health products.
- **Connex 360 Vital Signs Monitor** — A connected patient monitor with configurable workflows, security features and an upgradeable platform.
- **Injectable medicines and anesthesia** — Specialty injectable pharmaceuticals, premixed drugs, inhaled anesthetics and hospital pharmacy products.
- **Service, training and support** — Technical support, clinical education, product maintenance, ordering assistance and digital self-service resources.

## Achievements

- Became the first commercial manufacturer of prepared IV solutions after its founding in 1931.
- Built a portfolio sold in more than 100 countries and used by more than 350 million patients annually.
- Completed the $12.5 billion acquisition of Hillrom in 2021, adding smart beds, patient monitoring, diagnostics and surgical technologies.
- Received U.S. FDA 510(k) clearance for the Novum IQ large-volume infusion pump with Dose IQ Safety Software in 2024.
- Completed the sale of its Vantive kidney-care business to Carlyle in January 2025 after announcing a $3.8 billion transaction value.
- Reported $11.2 billion in 2025 global sales from continuing operations and related activities.
- Published sustainability and corporate responsibility reports for more than 30 years.

## Latest updates

- **2026-07** — Reported second-quarter sales of $2.96 billion, up 5% reported and organic, and raised its full-year 2026 outlook.
- **2026-06** — Published its 2025 Sustainability Report with refreshed priorities and disclosed more than $32 million in community contributions, product donations and employee matching gifts.
- **2026-04** — Reported first-quarter sales from continuing operations of $2.7 billion and reiterated its then-current 2026 outlook.
- **2026-01** — Announced a multi-year connected-care partnership with MUSC Health focused on bedside workflows, nursing burden and patient safety.
- **2025-11** — The Baxter Foundation announced a $2.6 million, three-year grant to continue its Chicagoland STEM partnership with Northwestern University.
- **2025-09** — Andrew Hider became president and CEO, bringing an operations and industrial automation background to Baxter's next phase.
- **2025-01** — Completed the divestiture of the Vantive kidney-care business, sharpening Baxter's focus on hospital products, connected care and injectables.

## Links

- Website: https://www.baxter.com
- LinkedIn: https://www.linkedin.com/company/baxter-healthcare
- Twitter/X: https://x.com/baxter_intl
- Facebook: https://www.facebook.com/BaxterInternational/

---

Profile page: https://yespress.io/baxter-international-inc
Published by YesPress — https://yespress.io
Last updated: 2026-08-11